Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Rentschler Biopharma and ATUM announced the signing of a full CDMO licensing agreement for the Leap-In Transposase platform.
read more
Rentschler obtained the certificate of GMP compliance and the pharmaceutical manufacturing license for the European market from the Austrian Agency for Health and Food Safety.
read more
Wednesday, December 07, 2022
Earlier this year, the company kicked off a program with MassBioEd and Worcester Polytechnic Institute (WPI) to train people re-joining the workforce for stable, attractive biotech manufacturing opportunities.
read more
Rentschler Fill Solutions GmbH has received notification from the Austrian Agency for Health and Food Safety that the pharmaceutical manufacturing license for the European market and the certificate for GMP conformity will be extended for an ...
read more
Rentschler Fill Solutions GmbH, a CMO and expert for aseptic fill and finish services, announced the appointment of Dr. Margit Klotz as General Manager Operations, effective August 1, 2018.
read more
Monday, November 19, 2018
Rentschler Fill Solutions GmbH has inaugurated its new state-of-the-art facility in Rankweil, Austria.
read more
Rentschler Fill Solutions GmbH announced the appointment of Dr. Friedrich Sernetz as Chief Executive Officer.
read more
Wednesday, October 04, 2017
Rentschler Biotechnologie GmbH announced the company has successfully transitioned into a European corporation (SE) with entry into the German commercial register on October 1, 2017.
read more
Rentschler Biotechnologie GmbH, a CDMO for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, have announced a strategic partnership to provide new state-of-the-art fill and finish ...
read more
Wednesday, September 13, 2023
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announced that it has received the cGMP Manufacturing Compliance Certificate, ...
read more
Vetter and Rentschler Biopharma have announced their strategic collaboration, to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.
read more
Wednesday, January 31, 2018
Rentschler Biopharma SE has appointed Dr. Ralf Otto as Chief Operating Officer (COO), effective February 1, 2018.
read more
Rentschler Biopharma SE announced that the company’s new state-of-the-art production line, formerly known as the Rentschler Biopharma Manufacturing Center (RBMC), in Milford, MA in the U.S. is now fully operational.
read more
Wednesday, December 20, 2023
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major client collaboration for its upcoming Rentschler Biopharma Manufacturing Center (RBMC) ...
read more
Rentschler Biopharma announced Prof. Dr. Nikolaus F. Rentschler, and CEO Dr. Frank Mathias have received the "EY Entrepreneur of the Year" Award 2019 in the category Industry.
read more